Violich Capital Management’s Pfizer PFE Stock Holding History

Violich Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$635K	Sell	26,350 -1,300	-5%	-$34K	0.07%	75
2026 Q1	$776K	Sell	27,650 -1,000	-3%	-$26.6K	0.09%	72
2025 Q4	$713K	Sell	28,650 -2,387	-8%	-$60.2K	0.08%	68
2025 Q3	$791K	Hold	31,037	–	–	0.09%	68
2025 Q2	$752K	Sell	31,037 -10,200	-25%	-$238K	0.11%	64
2025 Q1	$1.04M	Hold	41,237	–	–	0.14%	62
2024 Q4	$1.09M	Sell	41,237 -5,800	-12%	-$157K	0.14%	60
2024 Q3	$1.36M	Buy	47,037 +168	+0.4%	+$4.9K	0.18%	61
2024 Q2	$1.31M	Hold	46,869	–	–	0.18%	60
2024 Q1	$1.3M	Buy	46,869 +14,750	+46%	+$409K	0.19%	60
2023 Q4	$925K	Sell	32,119 -2,132	-6%	-$64.5K	0.15%	59
2023 Q3	$1.14M	Hold	34,251	–	–	0.19%	60
2023 Q2	$1.26M	Hold	34,251	–	–	0.2%	58
2023 Q1	$1.4M	Hold	34,251	–	–	0.24%	52
2022 Q4	$1.75M	Hold	34,251	–	–	0.31%	49
2022 Q3	$1.5M	Hold	34,251	–	–	0.28%	50
2022 Q2	$1.8M	Hold	34,251	–	–	0.31%	46
2022 Q1	$1.77M	Buy	34,251 +614	+2%	+$31.9K	0.26%	48
2021 Q4	$1.99M	Hold	33,637	–	–	0.29%	45
2021 Q3	$1.45M	Buy	33,637 +10,237	+44%	+$454K	0.23%	53
2021 Q2	$916K	Hold	23,400	–	–	0.15%	63
2021 Q1	$848K	Hold	23,400	–	–	0.15%	65
2020 Q4	$861K	Sell	23,400 -1,264	-5%	-$46.4K	0.17%	60
2020 Q3	$859K	Sell	24,664 -843	-3%	-$29.6K	0.18%	61
2020 Q2	$791K	Hold	25,507	–	–	0.17%	66
2020 Q1	$790K	Hold	25,507	–	–	0.21%	61
2019 Q4	$948K	Sell	25,507 -284	-1%	-$10.1K	0.21%	67
2019 Q3	$879K	Sell	25,791 -1,054	-4%	-$38.3K	0.21%	67
2019 Q2	$1.1M	Sell	26,845 -1,054	-4%	-$41.9K	0.27%	56
2019 Q1	$1.12M	Hold	27,899	–	–	0.28%	54
2018 Q4	$1.16M	Hold	27,899	–	–	0.33%	48
2018 Q3	$1.17M	Hold	27,899	–	–	0.27%	55
2018 Q2	$960K	Sell	27,899 -1,845	-6%	-$63K	0.24%	61
2018 Q1	$1M	Hold	29,744	–	–	0.27%	56
2017 Q4	$1.02M	Hold	29,744	–	–	0.26%	57
2017 Q3	$1.01M	Sell	29,744 -485	-2%	-$15.6K	0.27%	54
2017 Q2	$963K	Hold	30,229	–	–	0.28%	55
2017 Q1	$981K	Sell	30,229 -160	-0.5%	-$5.04K	0.3%	54
2016 Q4	$934K	Sell	30,389 -2,677	-8%	-$81.7K	0.29%	57
2016 Q3	$1.06M	Hold	33,066	–	–	0.37%	50
2016 Q2	$1.1M	Buy	33,066 +120	+0.4%	+$3.83K	0.35%	50
2016 Q1	$926K	Sell	32,946 -1,991	-6%	-$56.9K	0.3%	51
2015 Q4	$1.07M	Sell	34,937 -98	-0.3%	-$3.08K	0.35%	48
2015 Q3	$1.04M	Sell	35,035 -422	-1%	-$13.5K	0.37%	49
2015 Q2	$1.13M	Hold	35,457	–	–	0.37%	49
2015 Q1	$1.17M	Buy	35,457 +98	+0.3%	+$3.12K	0.38%	48
2014 Q4	$1.04M	Buy	35,359 +161	+0.5%	+$4.62K	0.33%	52
2014 Q3	$987K	Sell	35,198 -8,594	-20%	-$241K	0.32%	52
2014 Q2	$1.23M	Buy	43,792 +31,949	+270%	+$911K	0.41%	44
2014 Q1	$361K	Hold	11,843	–	–	0.13%	76
2013 Q4	$344K	Buy	11,843 +378	+3%	+$11K	0.12%	77
2013 Q3	$312K	Hold	11,465	–	–	0.12%	82
2013 Q2	$305K	Buy	+11,465	New	+$317K	0.12%	82

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Violich Capital Management's PFE Position: Q2 2026 in Review

Violich Capital Management reduced its Pfizer (PFE) stake by 4.7% in Q2 2026, selling an estimated $34K and leaving 26,350 shares worth $635K. The position accounts for 0.07% of the portfolio, ranked #75.

Violich Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.99M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Violich Capital Management held 26,350 shares of Pfizer worth $635K as of Q2 2026.
Violich Capital Management sold 1,300 Pfizer shares in Q2 2026, an estimated $34K.
Pfizer made up 0.07% of Violich Capital Management's portfolio in Q2 2026, its #75 holding.
Violich Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Violich Capital Management's Pfizer position peaked at $1.99M in Q4 2021.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.